EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer - Contacts and Locations

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

This study has been completed.

Study NCT00035100. Last updated on January 25, 2008. Information provided by Novartis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00035100

Locations


United States, California
	California Pacific Medical Center
	San Francisco, California, United States, 94116

United States, Connecticut
	St. Francis Hospital
	Hartford, Connecticut, United States, 06105

United States, Maryland
	The Sidney Kimmel Comprehensive Cancer Center
	Baltimore, Maryland, United States, 21287

United States, Nevada
	Women's Cancer Center of Nevada
	Las Vegas, Nevada, United States, 89109

United States, Rhode Island
	Women and Infants Hospital
	Providence, Rhode Island, United States, 02905

United States, Tennessee
	Sarah Cannon Cancer Center
	Nashville, Tennessee, United States, 37203

United States, Utah
	Huntsman Cancer Institute, University of Utah
	Salt Lake City, Utah, United States, 84112

Sponsors and Collaborators

Novartis

Investigators


Study Chair:	Novartis	Novartis